CHICAGO (GenomeWeb) – Aprima Medical Software, a Dallas-based maker of ambulatory electronic health records, has become the latest health IT vendor to announce plans to integrate the ActX genomic decision support platform into its EHRs, the two companies said Tuesday.

The integration will allow Aprima EHR users to receive alerts about potentially harmful drug-genomic interactions when writing electronic prescriptions. It also will make full genomic profiles available directly through patient charts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.